Search

Author/Creator Porter, Tim

1. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022)

Authors:
Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;...
Journal:
Lancet
Issue:
Volume 399:Issue 10323(2022)
Page Start:
447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Surgery for pathological T3a, T3b and lymph node positive, prostate cancer: surgical, functional and oncological outcomes. (January 2022)

Authors:
Gilliland, Niall; Vennam, Sarath; Geraghty, Robert; Peacock, Julian; Crockett, Matthew; Kearley, Samantha; Oxley, Jon; Porter, Tim; Waine, Elizabeth; Aning, Jonathan; Rowe, Edward; Koupparis, Anthony
Journal:
Journal of clinical urology
Issue:
Volume 15:Number 1(2022)
Page Start:
25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search